Ultragenyx Pharmaceutical (RARE) EPS (Diluted) (2017 - 2026)

Ultragenyx Pharmaceutical (RARE) EPS (Diluted) (2017 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Diluted) (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	0.00
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.15
4	NuCana	279.75 Bn	279.75 Bn	-	-368,323.02
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	4.02
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	6.75
7	Belite Bio	62.51 Bn	62.51 Bn	-	0.00
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	7.33
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-2.29
10	Ultragenyx Pharmaceutical	2.72 Bn	2.31 Bn	106.00 Mn	-1.84

Download Data